Tech Company M&A Transactions

EUSA Pharma Acquisition

Based in Langhorne, EUSA Pharma was acquired by Jazz Pharmaceuticals. Jazz Pharmaceuticals said the transaction price was $700 million.

Transaction Overview

Company Name
Announced On
4/27/2012
Transaction Type
M&A
Amount
$700,000,000
M&A Terms
The acquisition will be paid for with $650 million in cash and a potential $50 million milestone payable in cash.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1717 Langhorne-Newtown Road 201
Langhorne, PA 19047
USA
Email Address
Overview
EUSA Pharma is a specialty pharmaceutical company with a strong and growing portfolio of specialized hospital medicines focused on oncology, pain control and critical care, which it markets predominantly in Europe and the US (as the company's name suggests).
Profile
EUSA Pharma LinkedIn Company Profile
Social Media
EUSA Pharma Company Twitter Account
Company News
EUSA Pharma News
Facebook
EUSA Pharma on Facebook
YouTube
EUSA Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bryan Morton
  Bryan Morton LinkedIn Profile  Bryan Morton Twitter Account  Bryan Morton News  Bryan Morton on Facebook
Chief Financial Officer
David Cook
  David Cook LinkedIn Profile  David Cook Twitter Account  David Cook News  David Cook on Facebook
Chief Medical Officer
Tim Corn
  Tim Corn LinkedIn Profile  Tim Corn Twitter Account  Tim Corn News  Tim Corn on Facebook
President
Jim Mitchum
  Jim Mitchum LinkedIn Profile  Jim Mitchum Twitter Account  Jim Mitchum News  Jim Mitchum on Facebook
VP - Bus. Development
Anuj Madhok
  Anuj Madhok LinkedIn Profile  Anuj Madhok Twitter Account  Anuj Madhok News  Anuj Madhok on Facebook
VP - General Counsel
Zoe Evans
  Zoe Evans LinkedIn Profile  Zoe Evans Twitter Account  Zoe Evans News  Zoe Evans on Facebook
VP - Human Resources
Brian Jackson
  Brian Jackson LinkedIn Profile  Brian Jackson Twitter Account  Brian Jackson News  Brian Jackson on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/27/2012: CloudMine venture capital transaction
Next: 4/27/2012: OncoPep venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary